PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 56 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,000 | -76.1% | 15,000 | -76.9% | 0.01% | -76.2% |
| Q4 2020 | $218,000 | -21.9% | 65,000 | -18.2% | 0.04% | 0.0% |
| Q3 2020 | $279,000 | -21.2% | 79,470 | +3.2% | 0.04% | -40.8% |
| Q2 2020 | $354,000 | -0.6% | 76,970 | -28.5% | 0.07% | -52.0% |
| Q1 2020 | $356,000 | -38.2% | 107,577 | +14.0% | 0.15% | -7.5% |
| Q4 2019 | $576,000 | +10.8% | 94,351 | -24.4% | 0.16% | -42.9% |
| Q3 2019 | $520,000 | -52.2% | 124,788 | +50.5% | 0.28% | -79.5% |
| Q2 2019 | $1,088,000 | – | 82,931 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
| NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
| DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
| Platform Technology Partners | 141,025 | $474,000 | 0.23% |
| Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
| Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
| Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |